SunWay Biotech Co., LTD. (TPEX:1271) agreed to acquire Bora Health Inc from Bora Pharmaceuticals Co., LTD. (TPEX:6472) and others for TWD 1.6 billion on August 21, 2023. The share transfer ratio is every 0.89 share of Bora Health will exchange for 1 share of SunWay Biotech. The board of director of Bora Pharmaceuticals approved the transaction.

As of October 13, 2023, shareholders of SunWay Biotech and Bora Health approved the deal. SunWay will acquire 22,618,880 shares of Bora Health and issue 25,414,472 shares as part of consideration. The transaction is expected to close on November 1, 2023.

Siao-Yun Wu acted as legal advisor to Bora Pharmaceuticals.